We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
Veeva Systems (VEEV - Free Report) ended the recent trading session at $291.21, demonstrating a -1.37% change from the preceding day's closing price. This change lagged the S&P 500's 1.12% loss on the day. Meanwhile, the Dow lost 0.84%, and the Nasdaq, a tech-heavy index, lost 1.9%.
Shares of the provider of cloud-based software services for the life sciences industry witnessed a loss of 2.17% over the previous month, trailing the performance of the Medical sector with its loss of 0.26%, and the S&P 500's gain of 1.26%.
Market participants will be closely following the financial results of Veeva Systems in its upcoming release. The company plans to announce its earnings on November 20, 2025. The company's upcoming EPS is projected at $1.95, signifying a 11.43% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $791.88 million, up 13.25% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $7.78 per share and a revenue of $3.14 billion, demonstrating changes of +17.88% and +18.14%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Veeva Systems presently features a Zacks Rank of #2 (Buy).
In the context of valuation, Veeva Systems is at present trading with a Forward P/E ratio of 37.96. This expresses a premium compared to the average Forward P/E of 36.95 of its industry.
We can also see that VEEV currently has a PEG ratio of 1.62. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Medical Info Systems industry stood at 3.03 at the close of the market yesterday.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 64, this industry ranks in the top 26% of all industries, numbering over 250.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
Veeva Systems (VEEV - Free Report) ended the recent trading session at $291.21, demonstrating a -1.37% change from the preceding day's closing price. This change lagged the S&P 500's 1.12% loss on the day. Meanwhile, the Dow lost 0.84%, and the Nasdaq, a tech-heavy index, lost 1.9%.
Shares of the provider of cloud-based software services for the life sciences industry witnessed a loss of 2.17% over the previous month, trailing the performance of the Medical sector with its loss of 0.26%, and the S&P 500's gain of 1.26%.
Market participants will be closely following the financial results of Veeva Systems in its upcoming release. The company plans to announce its earnings on November 20, 2025. The company's upcoming EPS is projected at $1.95, signifying a 11.43% increase compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $791.88 million, up 13.25% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $7.78 per share and a revenue of $3.14 billion, demonstrating changes of +17.88% and +18.14%, respectively, from the preceding year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Veeva Systems presently features a Zacks Rank of #2 (Buy).
In the context of valuation, Veeva Systems is at present trading with a Forward P/E ratio of 37.96. This expresses a premium compared to the average Forward P/E of 36.95 of its industry.
We can also see that VEEV currently has a PEG ratio of 1.62. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. The average PEG ratio for the Medical Info Systems industry stood at 3.03 at the close of the market yesterday.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 64, this industry ranks in the top 26% of all industries, numbering over 250.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.